Health care industry
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Jamie Dimon, chief executive officer of JPMorgan Chase & Co., at the Institute of International Finance (IIF) during the annual meetings of the IMF and World Bank in Washington, DC, US, on Thursday, Oct. 24, 2024. Kent Nishimura | Bloomberg | Getty Images San Francisco, famed for its abundance of hoodie-clad tech workers, was overrun […]
Read More
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
U.S. President Joe Biden speaks about prescription drug costs during an event at NHTI Concord Community College in Concord, New Hampshire, U.S., October 22, 2024. REUTERS/Elizabeth Frantz Elizabeth Frantz | Reuters The Biden administration on Friday unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off […]
Read More
FDA officially authorizes Zyn nicotine pouches for sale following health review
Zyn nicotine cases and pouches are seen on a table in New York City on Jan. 29, 2024. Michael M. Santiago | Getty Images The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an “extensive scientific review” about their safety. In a release Thursday, the agency said it had found the popular […]
Read More
Medicare’s new $2,000 cap on out-of-pocket drug costs could save enrollees thousands, AARP says
Most Medicare patients who hit the new $2,000 cap on out-of-pocket spending for prescription drugs could see massive savings, despite changes in premiums, according to a report released Thursday by AARP. The findings suggest the cap could be a huge benefit to older adults in Medicare who struggle to afford high-cost drugs for cancer, rheumatoid […]
Read More
Stocks pop on cool inflation, hot bank earnings — plus, new rules on biotech exports to China
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: Wall Street surged Wednesday thanks to the second encouraging inflation report this week and a batch of strong bank earnings. The consumer price index, excluding […]
Read More
Bristol Myers Squibb says Alzheimer’s is the biggest market for new schizophrenia drug
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb believes Alzheimer’s is the largest market for its newly approved schizophrenia drug, Cobenfy, which it expects to eventually generate billions of dollars in revenue. In […]
Read More
FDA bans Red No. 3, artificial coloring used in beverages, candy and other foods
Red Dye # 3 can have deleterious health effects. The cherries are from a canned fruit cocktail sold at the Dollar TreeIsland Choice Diced Fruit Cocktail (cherries have red #3). Linnea Bullion | The Washington Post | Getty Images The Food and Drug Administration said Wednesday it’s banning the use of Red No. 3, a […]
Read More
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good afternoon from San Francisco! This week, Ashley and I are attending the annual JPMorgan Health Care Conference – the largest gathering of biotech and pharma execs, […]
Read More
FDA proposes putting nutrition info on the front of food packages
Nutrition labels are seen on food packaging in Miami, Florida. Joe Raedle | Getty Images The Food and Drug Administration on Tuesday proposed a new rule for nutrition labels on packaged food and drinks that’s intended to help Americans make healthier choices at a glance. Under the new rule, which shoppers could see as early as 2028, […]
Read More
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg | Getty Images Eli Lilly cut its revenue guidance on Tuesday as it said demand for its weight loss and diabetes drugs would not meet its lofty expectations. The drugmaker’s […]
Read More